Taiwanese Journal of Obstetrics and Gynecology
Volume 47, Issue 2 , Pages 157-162 , June 2008

First- and Second-trimester Down Syndrome Screening: Current Strategies and Clinical Guidelines

  • Sheng-Wen Shaw

      Affiliations

    • Department of Obstetrics and Gynecology, Chang Cung Memorial Hospital, Linkou Medical Center, Taipei, Taiwan
    • Chang Cung University College of Medicine, Taoyuan, Taipei, Taiwan
    • ,
  • Jenn-Jeih Hsu

      Affiliations

    • Chang Cung University College of Medicine, Taoyuan, Taipei, Taiwan
    • Department of Obstetrics and Gynecology, Chang CungMemorial Hospital, Taipei, Taiwan
    • ,
  • Chien-Nan Lee

      Affiliations

    • Department Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Ching-Hua Hsiao

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei City Hospital, Branch for Women and Children, Taipei, Taiwan
    • ,
  • Chih-Ping Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • ,
  • T'sang-T'ang Hsieh

      Affiliations

    • Chang Cung University College of Medicine, Taoyuan, Taipei, Taiwan
    • Department of Obstetrics and Gynecology, Chang CungMemorial Hospital, Taipei, Taiwan
    • ,
  • Po-Jen Cheng

      Affiliations

    • Department of Obstetrics and Gynecology, Chang Cung Memorial Hospital, Linkou Medical Center, Taipei, Taiwan
    • Chang Cung University College of Medicine, Taoyuan, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Po-Jen Cheng, Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, 5, Fu-Shin Street, Taoyuan 333, Taiwan

,Accepted 10 April 2008.

References 

  1. Korenberg JR , Chen XN , Schipper R , et al.   Down syndrome phenotypes: the consequences of chromosomal imbalance . Proc Natl Acad Sci USA . 1994;91:4997–5001
  2. Shaw SW , Chen CP , Cheng PJ , et al.   Gene dosage change of TPTE and BAGE2 and breakpoint analysis in Robertsonian Down syndrome . J Hum Genet . 2008;53:136–143
  3. Martin JA , Hamilton BE , Sutton PD , Ventura SJ , Menacker F , Munson ML . Births: final data for 2002 . Natl Vital Stat Rep . 2003;52:1–113
  4. Mathews TJ , Hamilton BE . Mean age of mother, 1970–2000 . Natl Vital Stat Rep . 2002;51:1–13
  5. Hsieh TT , Hsu JJ , Cheng PJ , Lee CN , Jou HJ , Chen CP . Total hCG versus free beta-hCG combined with alpha-fetoprotein for Down syndrome screening in Taiwan . Taiwan J Obstet Gynecol . 2007;46:230–235
  6. Hsu JJ , Hsieh TT , Hsieh FJ . Down syndrome screening in an Asian population using alpha-fetoprotein and free betahCG: a report of the Taiwan Down Syndrome Screening Group . Obstet Gynecol . 1996;87:943–947
  7. Jou HJ , Kuo YS , Hsu JJ , Shyu MK , Hsieh TT , Hsieh FJ . The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening . Prenat Diagn . 2005;25:665–670
  8. Jou HJ , Shyu MK , Chen SM , Shih JC , Hsu JJ , Hsieh FJ . Maternal serum screening for down syndrome by using alpha-fetoprotein and human chorionic gonadotropin in an asian population. A prospective study . Fetal Diagn Ther . 2000;15:108–111
  9. Snijders RJ , Noble P , Sebire N , Souka A , Nicolaides KH . UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group . Lancet . 1998;352:343–346
  10. Malone FD , Canick JA , Ball RH , et al.   First-trimester or second-trimester screening, or both, for Down's syndrome . N Engl J Med . 2005;353:2001–2011
  11. ACOG Committee on Practice Bulletins  . ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities . Obstet Gynecol . 2007;109:217–227
  12. Cuckle HS , Wald NJ , Lindenbaum RH . Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome . Lancet . 1984;323:926–929
  13. Cuckle HS , Wald NJ , Thompson SG . Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level . Br J Obstet Gynaecol . 1987;94:387–402
  14. Merkatz IR , Nitowsky HM , Macri JN , Johnson WE . An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities . Am J Obstet Gynecol . 1984;148:886–894
  15. Wald NJ , Watt HC , Hackshaw AK . Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters . N Engl J Med . 1999;341:461–467
  16. Canick JA , Knight GJ , Palomaki GE , Haddow JE , Cuckle HS , Wald NJ . Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome . Br J Obstet Gynaecol . 1988;95:330–333
  17. Wald NJ , Cuckle HS , Densem JW , et al.   Maternal serum screening for Down's syndrome in early pregnancy . BMJ . 1988;297:883–887
  18. Van Lith JM , Pratt JJ , Beekhuis JR , Mantingh A . Secondtrimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome . Prenat Diagn . 1992;12:801–806
  19. Wald NJ , Rodeck C , Hackshaw AK , Rudnicka A . SURUSS in perspective . BJOG . 2004;111:521–531
  20. Tseng JJ , Chou MM , Lo FC , Lai HY , Chen MH , Ho ES . Detection of chromosome aberrations in the second trimester using genetic amniocentesis: experience during 1995–2004 . Taiwan J Obstet Gynecol . 2006;45:39–41
  21. Krantz DA , Larsen JW , Buchanan PD , Macri JN . Firsttrimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A . Am J Obstet Gynecol . 1996;174:612–616
  22. Nicolaides KH , Azar G , Byrne D , Mansur C , Marks K . Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy . BMJ . 1992;304:867–869
  23. Wald NJ , Hackshaw AK . Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome . Prenat Diagn . 1997;17:821–829
  24. Cheng PJ , Chang SD , Shaw SW , Soong YK . Nuchal translucency thickness in fetuses with chromosomal translocation at 11–12 weeks of gestation . Obstet Gynecol . 2005;105:1058–1062
  25. Cheng PJ , Shaw SW , Shih JC , Soong YK . Monozygotic twins discordant for monosomy 21 detected by first-trimester nuchal translucency screening . Obstet Gynecol . 2006;107:538–541
  26. Cheng PJ , Shaw SW , Soong YK . Association of fetal choroid plexus cysts with trisomy 18 in a population previously screened by nuchal translucency thickness measurement . J Soc Gynecol Investig . 2006;13:280–284
  27. Shaw SW , Cheng PJ , Chueh HY , Chang SD , Soong YK . Ectopia cordis in a fetus with trisomy 18 . J Clin Ultrasound . 2006;34:95–98
  28. Spencer K , Macri JN , Aitken DA , Connor JM . Free beta-hCG as first-trimester marker for fetal trisomy . Lancet . 1992;339:1480
  29. Wald N , Stone R , Cuckle HS , et al.   First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome . BMJ . 1992;305:28
  30. Gilbert RE, Augood C, Gupta R, Ades AE, Logan S, Sculpher M, et al. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies . BMJ . 2001;323:423–425
  31. Greene N , Platt LD . In response to ‘Certificate of competence in performing specific procedures or tests in screening practice’ . Prenat Diagn . 2004;24:315
  32. Cicero S , Curcio P , Papageorghiou A , Sonek J , Nicolaides K . Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study . Lancet . 2001;358:1665–1667
  33. Matias A , Montenegro N , Areias JC , Brandao O . Anomalous fetal venous return associated with major chromosomopathies in the late first trimester of pregnancy . Ultrasound Obstet Gynecol . 1998;11:209–213
  34. Huggon IC , DeFigueiredo DB , Allan LD . Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11–14 weeks of gestation . Heart . 2003;89:1071–1073
  35. Marteau TM , Kidd J , Michie S , Cook R , Johnston M , Shaw RW . Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial . J Psychosom Obstet Gynaecol . 1993;14:185–196
  36. Canini S , Prefumo F , Famularo L , Venturini PL , Palazzese V , De Biasio P . Comparison of first trimester, second trimester and integrated Down's syndrome screening results in unaffected pregnancies . Clin Chem Lab Med . 2002;40:600–603
  37. Wapner R , Thom E , Simpson JL , et al.   First-trimester screening for trisomies 21 and 18 . N Engl J Med . 2003;349:1405–1413
  38. Benn P , Wright D , Cuckle H . Practical strategies in contingent sequential screening for Down syndrome . Prenat Diagn . 2005;25:645–652
  39. Cuckle H , Benn P , Wright D . Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters . Semin Perinatol . 2005;29:252–257
  40. Maymon R , Neeman O , Shulman A , Rosen H , Herman A . Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: another double trouble . Prenat Diagn . 2005;25:746–750
  41. Meyers C , Adam R , Dungan J , Prenger V . Aneuploidy in twin gestations: when is maternal age advanced? . Obstet Gynecol . 1997;89:248–251

PII: S1028-4559(08)60073-X

doi: 10.1016/S1028-4559(08)60073-X

Taiwanese Journal of Obstetrics and Gynecology
Volume 47, Issue 2 , Pages 157-162 , June 2008

Article Tools